XGES.L vs. XBCU.L
XGES.L (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) and XBCU.L (Xtrackers Bloomberg Commodity ex-Agriculture & Livestock Swap UCITS ETF 2C) are both exchange-traded funds - XGES.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD, while XBCU.L is a Commodities fund tracking the Bloomberg ex-Agriculture and Livestock 15/30 Capped 3 Month Forward. Both are passively managed. Over the past 3 years, XGES.L returned 1.51%/yr vs 16.51%/yr for XBCU.L. At a 0.05 correlation, their price movements are largely independent. XGES.L charges 0.35%/yr vs 0.29%/yr for XBCU.L.
Performance
XGES.L vs. XBCU.L - Performance Comparison
Loading charts...
Different Trading Currencies
XGES.L is traded in GBP, while XBCU.L is traded in USD. To make them comparable, the XBCU.L values have been converted to GBP using the latest available exchange rates.
Returns By Period
In the year-to-date period, XGES.L achieves a -0.81% return, which is significantly lower than XBCU.L's 23.65% return.
XGES.L
- 1D
- 4.22%
- 1M
- 6.75%
- YTD
- -0.81%
- 6M
- -4.42%
- 1Y
- 26.00%
- 3Y*
- 1.51%
- 5Y*
- —
- 10Y*
- —
XBCU.L
- 1D
- -0.49%
- 1M
- 1.47%
- YTD
- 23.65%
- 6M
- 25.36%
- 1Y
- 46.95%
- 3Y*
- 16.51%
- 5Y*
- 16.80%
- 10Y*
- 10.77%
XGES.L vs. XBCU.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XGES.L Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -0.81% | 11.22% | -1.38% | -7.92% | -8.46% |
XBCU.L Xtrackers Bloomberg Commodity ex-Agriculture & Livestock Swap UCITS ETF 2C | 23.65% | 17.11% | 10.54% | -14.47% | 1.20% |
Correlation
The correlation between XGES.L and XBCU.L is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Jul 21, 2022 | 0.05 |
The correlation between XGES.L and XBCU.L shifts across timeframes, from -0.08 (1 year) to 0.05 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XGES.L vs. XBCU.L — Risk / Return Rank
XGES.L
XBCU.L
XGES.L vs. XBCU.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) and Xtrackers Bloomberg Commodity ex-Agriculture & Livestock Swap UCITS ETF 2C (XBCU.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XGES.L | XBCU.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.08 | ||
| Sortino ratioReturn per unit of downside risk | -0.91 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.46 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 1.69 | 5.86 | -4.17 |
| Martin ratioReturn relative to average drawdown | 4.09 | 14.41 | -10.32 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XGES.L | XBCU.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.45 | 2.53 | -1.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.92 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.63 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.12 | 0.31 | -0.43 |
Drawdowns
XGES.L vs. XBCU.L - Drawdown Comparison
The maximum XGES.L drawdown since its inception was -35.79%, smaller than the maximum XBCU.L drawdown of -52.27%. Use the drawdown chart below to compare losses from any high point for XGES.L and XBCU.L.
Loading charts...
Drawdown Indicators
| XGES.L | XBCU.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.79% | -52.27% | +16.48% |
Max Drawdown (1Y)Largest decline over 1 year | -15.29% | -7.97% | -7.32% |
Max Drawdown (3Y)Largest decline over 3 years | -25.52% | -15.39% | -10.13% |
Max Drawdown (5Y)Largest decline over 5 years | — | -27.98% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -31.79% | — |
Current DrawdownCurrent decline from peak | -12.59% | -1.94% | -10.65% |
Average DrawdownAverage peak-to-trough decline | -17.98% | -24.34% | +6.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.34% | 3.25% | +3.09% |
Volatility
XGES.L vs. XBCU.L - Volatility Comparison
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) has a higher volatility of 6.45% compared to Xtrackers Bloomberg Commodity ex-Agriculture & Livestock Swap UCITS ETF 2C (XBCU.L) at 4.17%. This indicates that XGES.L's price experiences larger fluctuations and is considered to be riskier than XBCU.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XGES.L | XBCU.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.45% | 4.17% | +2.28% |
Volatility (6M)Calculated over the trailing 6-month period | 13.62% | 15.25% | -1.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.84% | 18.47% | -0.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.27% | 18.16% | +0.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.27% | 17.18% | +1.09% |
XGES.L vs. XBCU.L - Expense Ratio Comparison
XGES.L has a 0.35% expense ratio, which is higher than XBCU.L's 0.29% expense ratio.
Dividends
XGES.L vs. XBCU.L - Dividend Comparison
Neither XGES.L nor XBCU.L has paid dividends to shareholders.
Frequently Asked Questions
XGES.L and XBCU.L have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XBCU.L is cheaper at 0.29% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XBCU.L is cheaper with a 0.29% expense ratio, compared with 0.35% for XGES.L.
XGES.L is categorized as Health & Biotech Equities, while XBCU.L is Commodities. XGES.L tracks MSCI World/Health Care NR USD, while XBCU.L tracks Bloomberg ex-Agriculture and Livestock 15/30 Capped 3 Month Forward. Their fees differ too: 0.35% for XGES.L and 0.29% for XBCU.L.
Find the right allocation for XGES.L and XBCU.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer